Alexandre Favre

Alexandre Favre has extensive work experience, starting in 2002 with Mazars as a Senior Manager in Transaction Services. Alexandre then joined Sanofi in 2010, where they held various finance roles including Head of Financial Investments & Legal Restructuring, CFO Nordics & Baltics and Head of Finance Diabetes Cardiovascular. Their most recent role at Sanofi was Head of Finance Clinical Development. In 2022, they became the Chief Financial Officer at TheraPanacea.

Alexandre Favre attended École Polytechnique from 1997 to 2000. Alexandre did not pursue a specific degree or field of study during this time. Following their education at École Polytechnique, they enrolled at Mines Paris from 2000 to 2002. No specific degree or field of study was mentioned during their tenure at Mines Paris.